Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Wang, Yan Yang ^a   Li, Xiu Zhong ^a   Wang, Li Bing ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CELL ACTIVITY; CELL LINEAGE; DISEASE SEVERITY; ENDOCRINE FUNCTION; ENGRAFTMENT; HUMAN; HYPOXIA; IMMUNOMODULATION; LUNG ALVEOLUS EPITHELIUM; LUNG GAS EXCHANGE; LUNG PARENCHYMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; MULTIPOTENT STEM CELL; NONHUMAN; PARACRINE SIGNALING; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; THERAPY EFFECT; UMBILICAL CORD BLOOD; ANIMAL; CYTOLOGY; MESENCHYMAL STROMA CELL; RESPIRATORY DISTRESS SYNDROME, ADULT;

ACUTE LUNG INJURY; ANIMALS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84877045370     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt193     Document Type: Review

References (54)

1. Incidence and outcomes of acute lung injury. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD, N Engl J Med 2005 353 1685 1693 10.1056/NEJMoa050333 16236739
2. Functional disability 5 years after acute respiratory distress syndrome. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM, Canadian Critical Care Trials Group, N Engl J Med 2011 364 1293 1304 10.1056/NEJMoa1011802 21470008
3. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. Cepkova M, Matthay MA, J Intensive Care Med 2006 21 119 143 10.1177/0885066606287045 16672636
4. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network, N Engl J Med 2000 342 1301 1308 10793162
5. Comparison of two fluid-management strategies in acute lung injury. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, de Boisblanc B, Connors AF Jr, Hite RD, Harabin AL, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, N Engl J Med 2006 354 2564 2575 16714767
6. Therapeutic strategies for severe acute lung injury. Diaz JV, Brower R, Calfee CS, Matthay MA, Crit Care Med 2010 38 1644 1650 10.1097/CCM. 0b013e3181e795ee 20562704
7. Pluripotency of mesenchymal stem cells derived from adult marrow. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM, Nature 2002 418 41 49 10.1038/nature00870 12077603
8. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A, Development 2001 128 5181 5188 11748153
9. Stem cells and cell therapy approaches in lung biology and diseases. Sueblinvong V, Weiss DJ, Transl Res 2010 156 188 205 10.1016/j.trsl.2010.06.007 20801416
10. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, Suzuki T, Sasaki H, J Immunol 2004 172 1266 1272 14707105
11. Potential application of mesenchymal stem cells in acute lung injury. Lee JW, Gupta N, Serikov V, Matthay MA, Expert Opin Biol Ther 2009 9 1259 1270 10.1517/14712590903213651 19691441
12. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP, Transplantation 1968 6 230 247 10.1097/00007890-196803000-00009 5654088
13. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606
14. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, Spees JL, Weiss DJ, Am J Respir Crit Care Med 2008 177 701 711 10.1164/rccm.200706- 859OC 18063840
15. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC, Stem Cells 2004 22 1330 1337 10.1634/stemcells.2004-0013 15579650
16. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Miao Z, Jin J, Chen L, Zhu J, Huang W, Zhao J, Qian H, Zhang X, Cell Biol Int 2006 30 681 687 10.1016/j.cellbi.2006. 03.009 16870478
17. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL, Circ Res 2008 102 77 85 10.1161/CIRCRESAHA.107.159475 17967785
18. Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Hoffman AM, Paxson JA, Mazan MR, Davis AM, Tyagi S, Murthy S, Ingenito EP, Stem Cells Dev 2011 20 1779 1792 10.1089/scd.2011.0105 21585237
19. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Prockop DJ, Gregory CA, Spees JL, Proc Natl Acad Sci U S A 2003 100 11917 11923 10.1073/pnas.1834138100 13679583
20. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR, Science 1999 284 143 147 10.1126/science.284.5411.143 10102814
21. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW, Chest 2010 138 965 972 10.1378/chest.10-0518 20923800
22. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ, Cell Stem Cell 2009 5 54 63 10.1016/j.stem.2009.05. 003 19570514
23. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ, Proc Natl Acad Sci U S A 2006 103 17438 17443 10.1073/pnas.0608249103 17088535
24. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, Yarmush ML, PLoS One 2007 2 941 10.1371/journal.pone.0000941 17895982
25. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C, Am J Physiol Renal Physiol 2005 289 31 F42 10.1152/ajprenal.00007.2005 15713913
26. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Lee JW, Fang X, Krasnodembskaya A, Howard JP, Matthay MA, Stem Cells 2011 29 913 919 10.1002/stem.643 21506195
27. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ, Cell 2001 105 369 377 10.1016/S0092-8674(01)00328-2 11348593
28. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG, Proc Natl Acad Sci U S A 2003 100 8407 8411 10.1073/pnas.1432929100 12815096
29. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL, Am J Respir Cell Mol Biol 2005 33 145 152 10.1165/rcmb.2004-0330OC 15891110
30. Little evidence for developmental plasticity of adult hematopoietic stem cells. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL, Science 2002 297 2256 2259 10.1126/science.1074807 12215650
31. Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ, Am J Respir Crit Care Med 2006 173 171 179 10.1164/rccm.200502-309OC 16179642
32. Intravenous allogeneic human mesenchymal stem cells home to the site of injury and restore alveolar fluid clearance to a normal level in an ex vivo perfused human lung injured by E.coli endotoxin. Lee JW, Fang X, Song Y, McKenna DH, Read EJ, Matthay MA, Am J Respir Crit Care Med 2010 181 3773
33. Targeted cell replacement with bone marrow cells for airway epithelial regeneration. Wong AP, Dutly AE, Sacher A, Lee H, Hwang DM, Liu M, Keshavjee S, Hu J, Waddell TK, Am J Physiol Lung Cell Mol Physiol 2007 293 740 L752 10.1152/ajplung.00050.2007 17616650
34. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ, PLoS Med 2007 4 269 10.1371/journal.pmed.0040269 17803352
35. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA, J Immunol 2007 179 1855 1863 17641052
36. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA, Proc Natl Acad Sci U S A 2009 106 16357 16362 10.1073/pnas.0907996106 19721001
37. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG, Proc Natl Acad Sci U S A 2007 104 11002 11007 10.1073/pnas.0704421104 17569781
38. Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism. Geiser T, Atabai K, Jarreau PH, Ware LB, Pugin J, Matthay MA, Am J Respir Crit Care Med 2001 163 1384 1388 10.1164/ajrccm.163.6.2006131 11371405
39. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M, Am J Physiol Lung Cell Mol Physiol 2007 293 131 L141 10.1152/ajplung.00431.2006 17416739
40. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Curley GF, Hayes M, Ansari B, Shaw G, Ryan A, Barry F, O'Brien T, O'Toole D, Laffey JG, Thorax 2012 67 496 501 10.1136/thoraxjnl-2011-201059 22106021
41. Human mesenchymal stem cells modulate B-cell functions. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A, Blood 2006 107 367 372 10.1182/blood-2005- 07-2657 16141348
42. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Yi T, Song SU, Arch Pharm Res 2012 35 213 221 10.1007/s12272-012-0202-z 22370776
43. Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. Jarvinen L, Badri L, Wettlaufer S, Ohtsuka T, Standiford TJ, Toews GB, Pinsky DJ, Peters-Golden M, Lama VN, J Immunol 2008 181 4389 4396 18768898
44. The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Torchia EC, Childs C, Shade T, Tadjali M, Lara A, Nozik-Grayck E, Malkoski S, Sorrentino B, Meyrick B, Klemm D, Rojas M, Stem Cells 2011 29 725 735 10.1002/stem.604 21312316
45. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME, Steele C, Rincon M, Weiss DJ, Stem Cells 2011 29 1137 1148 10.1002/stem.656 21544902
46. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4 + CD25+ Forkhead Boxp3 (FOXP3) + regulatory T cells and balancing anti- and pro-inflammatory factors. Sun J, Han ZB, Liao W, Yang SG, Yang Z, Yu J, Meng L, Wu R, Han ZC, Cell Physiol Biochem 2011 27 587 596 10.1159/000329980 21691076
47. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, Dallegri F, Ottonello L, Pistoia V, Stem Cells 2008 26 151 162 10.1634/stemcells.2007-0416 17932421
48. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, Liles WC, Stewart DJ, Am J Respir Crit Care Med 2010 182 1047 1057 10.1164/rccm.201001-0010OC 20558630
49. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA, Stem Cells 2010 28 2229 2238 10.1002/stem.544 20945332
50. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Gupta N, Krasnodembskaya A, Kapetanaki M, Mouded M, Tan X, Serikov V, Matthay MA, Thorax 2012 67 533 539 10.1136/thoraxjnl-2011- 201176 22250097
51. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coli-induced acute lung injury in mice. Kim ES, Chang YS, Choi SJ, Kim JK, Yoo HS, Ahn SY, Sung DK, Kim SY, Park YR, Park WS, Respir Res 2011 12 108 10.1186/1465-9921-12-108 21843339
52. Clinical applications of mesenchymal stem cells. Wang SH, Qu XB, Zhao RC, J Hematol Oncol 2012 5 19 10.1186/1756-8722-5-19 22546280
53. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R, Kreidieh NM, El-Sabban M, Bazarbachi A, J Neuroimmunol 2010 227 185 189 10.1016/j.jneuroim.2010.07.013 20728948
54. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Perez-Simon JA, Lopez-Villar O, Andreu EJ, Rifon J, Muntion S, Campelo MD, Sanchez-Guijo FM, Martinez C, Valcarcel D, Canizo CD, Haematologica 2011 96 1072 1076 10.3324/haematol.2010.038356 21393326